Plasma levels of C-reactive protein after coronary stent implantation

European Heart Journal

Volumn 21, Issue 14, 2000, Pages 1152-1158

  Gottsauner Wolf, M ^a,b   Zasmeta, G ^a   Hornykewycz, S ^a   Nikfardjam, M ^a   Stepan, E ^a   Wexberg, P ^a   Zorn, G ^a   Glogar, D ^a   Probst, P ^a   Maurer, G ^a   Huber, K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

C reactive protein; Coronary artery disease; Coronary stent; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; COUMARIN ANTICOAGULANT; DIPYRIDAMOLE; PHENPROCOUMON; TICLOPIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; HUMAN; IMPLANTATION; MALE; PLASMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ASPIRIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PHENPROCOUMON; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; STENTS; TICLOPIDINE;

EID: 0034662069     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1987     Document Type: Article

References (33)

1. Nobuyoshi M, Kimura T, Nosaka H. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 12:1988;616-623.
2. Gottsauner-Wolf M, Moliterno DJ, Lincoff AM, Topol EJ. Restenosis - an open file. Clin Cardiol. 19:1996;347-356.
3. Fischman DL, Leon ML, Baim DS. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
4. Serruys P, de Jaegere P, Kiemeniej F. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
5. Schomig A, Neumann FJ, Kastrati A. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med. 334:1996;1084-1089.
6. Kastrati A, Schühlen H, Hausleiter J. Restenosis after coronary stent placement and randomization to a 4 week combined antiplatelet or anticoagulant therapy. Six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. Circulation. 96:1997;462-467.
7. Huber K, Jörg M, Probst P. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis. Thromb Haemostas. 67:1992;209-213.
8. N Engl J Med. 330:1994;956-961.
9. Faxon DP, Sanborn TA, Haudenschild CC, Ryan TJ. Effect of antiplatelet therapy on restenosis after experimental angioplasty. Am J Cardiol. 53:1984;72C-76C.
10. Fingerle J, Muller RMK, Kuhn H, Pech M, Baumgartner HR. Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor Cilazapril: A study in balloon catheter-injured rat carotid arteries. Arterioscler Thromb Vasc Biol. 15:1995;1945-1950.
11. Currier JP, Pow TK, Minihan AC, Haudenschild CC, Faxon DP, Ryan TJ. Colchicin inhibits restenosis after iliac angioplasty in the atherosclerotic rabbit. Circulation. 80:1989;II-66.
12. Villa A, Guzman L, Chen W, Golomb G, Levy R, Topol E. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest. 93:1994;1243-1249.
13. Circulation. 86:1992;100-110.
14. O'Keefe JHJ, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzler GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol. 19:1992;1597-1600.
15. Pepine CJ, Hirshfeld JW, MacDonald RG. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation. 81:1990;1753-1761.
16. Liuzzo G, Buffon A, Biasucci LM. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 98:1998;2370-2376.
17. Bazzino O, Diaz R, Tajer C. Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3. The ECLA Collaborative Group. Am Heart J. 137:1999;322-331.
18. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
19. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 332:1995;635-641.
20. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 349:1997;462-466.
21. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J. 312:1996;1061-1065.
22. Ryan TJ, Faxon DP, Gunnar RM. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 78:1988;486-502.
23. Reiber JHC, Serruys PW, Kooijman CJ. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation. 71:1985;280-288.
24. Gottsauner-Wolf M, Sochor H, Mörtl D. Assessing coronary stenosis: quantitative coronary angiography versus visual estimation from cine-film or pharmacologic stress perfusion images. Eur Heart J. 17:1996;1167-1174.
25. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 144:1996;537-547.
26. Liuzzo G, Biasucci LM, Gallimore J. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
27. Tracy RP, Lemaitre RN, Psaty BM. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 17:1997;1121-1127.
28. Fuster V, Falk E, Fallon JT, Badimon L, Chesebro JH, Badimon JJ. The three processes leading to post PTCA restenosis: Dependence on the lesion substrate. Thromb Haemost. 74:1995;552-559.
29. Pietersma A, Kofflard M, de Wit LE. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 91:1995;1320-1325.
30. van Beusekom HM, van der Giessen WJ, van Suylen R, Bos E, Bosman FT, Serruys PW. Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol. 21:1993;45-54.
31. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 24:1994;1591-1601.
32. Fischman DL, Leon MB, Baim DS. A randomized comparison of stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
33. Cohen DJ, Krumholz HM, Sukin CA. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: Results from a randomized clinical trial. Circulation. 92:1995;2480-2487.